Mayne Pharma's new battle | Ray-Ban smart glasses are all the rage | Nestlé cuts 16,000 jobs
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Mayne Pharma's new battle | Ray-Ban smart glasses are all the rage | Nestlé cuts 16,000 jobs
-
Narrado por:
-
De:
ASX-listed Mayne Pharma saw its shares spike 14% after a court ruled that its acquirer cannot terminate its $672 million acquisition offer
Ray-Ban maker EssilorLuxottica just hit record sales as smart glasses go from nerdy to need one now
Nestlé’s new CEO is cutting 16,000 jobs as it looks to trim costs while also speeding up growth
_
Download the free app (App Store): http://bit.ly/FluxAppStore
Download the free app (Google Play): http://bit.ly/FluxappGooglePlay
Daily newsletter: https://bit.ly/fluxnewsletter
Flux on Instagram: http://bit.ly/fluxinsta
Flux on TikTok: https://www.tiktok.com/@flux.finance
—-
The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.
__
See omnystudio.com/listener for privacy information.